Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature
- PMID: 34693241
- PMCID: PMC8520171
- DOI: 10.1016/j.metop.2021.100136
Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature
Erratum in
-
Erratum regarding previously published articles.Metabol Open. 2023 Jan 21;17:100231. doi: 10.1016/j.metop.2023.100231. eCollection 2023 Mar. Metabol Open. 2023. PMID: 36992679 Free PMC article.
Abstract
Introduction: Immune response following viral infections has been suggested as a probable mechanism leading to subacute thyroiditis (SAT). A few cases of SAT following SARS-CoV-2 infection have been described since the outbreak of the pandemic in 2019. Cases of SAT after vaccination against influenza have also been reported. We describe two female patients with thyroiditis after vaccination against SARS-CoV-2.
Presentation of cases: The first patient presented with fever and pain in the thyroid area typical of SAT two weeks after vaccination with the BNT162B2 mRNA (Pfizer-BioNTech) COVID-19 vaccine. The second patient presented with biochemical and imaging features consistent with silent thyroiditis three weeks after vaccination with the ChAdOx1-S (AstraZeneca) vaccine. Both patients were asymptomatic prior to vaccination and PCR of nasopharyngeal swab for SARS-CoV-2 and other respiratory viruses associated with SAT was negative. Serology testing for measles, mumps, rubella, CMV and EBV viruses was suggestive of immunity. Antibody titre against spike S protein of SARS-CoV-2 was measured for both patients and was indicative of adequate post vaccination antibody response. Two months after initial assessment, both patients were euthyroid and asymptomatic.
Conclusions: Subacute as well as silent thyroiditis may rarely occur after vaccination against COVID-19. Further research is needed to investigate the prevalence and pathogenesis of thyroid dysfunction following vaccination against COVID-19.
Keywords: COVID-19; SARS-CoV-2; Silent thyroiditis; Subacute thyroiditis; Vaccine.
© 2021 The Authors.
Conflict of interest statement
The authors declare no competing interest relevant to the contents of this article.
Figures
References
-
- WHO COVID-19 dashboard. World Health Organization; Geneva: 2020. https://covid19.who.int/ (last cited: October 5th, 2021)
-
- Nyulassy S., Hnilica P., Buc M., Guman M., Hirschová V., Stefanovic J. Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab. 1977;45(2):270–274. doi: 10.1210/jcem-45-2-270. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
